OTC · Drug Manufacturers - Specialty & Generic

Delivra Health Brands Inc. (DHBUF) Stock

$0.08 +13.29% OTC: DHBUF Healthcare

Delivra Health Brands Inc., leveraging its operational subsidiaries, provides a varied selection of wellness and lifestyle products. These offerings are distributed to consumers and patients within regulated markets globally.

Valuation

MetricValue
Price$0.08
Market Cap$2.59M
P/E Ratio-3.40
P/B Ratio1.17
P/S Ratio0.31
EPS (TTM)$-0.03
52-Week High$0.26
52-Week Low$0.05
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-26.42%
ROA-14.19%
ROCE-19.32%
Gross Margin45.51%
Operating Margin-8.52%
Net Margin-8.99%
Debt/Equity0.79
Current Ratio3.29

Annual Financials (USD)

Metric20212022202320242025
Revenue$8.0M$8.0M$10.0M$12.0M$13.0M
Operating Profit$-7.0M$-6.0M$-1.0M$-1.0M$-1.0M
Net Profit$-29.0M$-7.0M$0$1.0M$-1.0M
EPS$-1.26$-0.28$-0.01$0.03$-0.03
Op Margin-88.5%-78.8%-13.9%-5.7%-4.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$19.0M$12.0M$11.0M$10.0M$10.0M
Total Liabilities$9.0M$8.0M$7.0M$5.0M$4.0M
Cash$4.0M$1.0M$3.0M$4.0M$2.0M
Borrowings$2.0M$2.0M$2.0M$2.0M$2.0M

Latest News

Delivra Health Brands launches LivRelief Itch Cream - ICYMI Proactive · Jul 4, 2026 Delivra Health Brands Announces Launch of LivRelief Itch Relief Cream in the Canadian Market MT Newswires · Jul 2, 2026 Delivra Health launches LivRelief Itch Relief Cream in Canada Proactive · Jul 2, 2026 Dow Jones ends holiday-shortened week at record high as jobs report misses Proactive · Jul 2, 2026 Delivra Health Brands Launches LivRelief (TM) Itch Relief Cream in the Canadian Market TMX Newsfile · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-10.0M$-4.0M$-1.0M$1.0M$-1.0M
Investing Cash Flow$12.0M$1.0M$3.0M$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$3.0M$-3.0M$2.0M$1.0M$-1.0M
Free Cash Flow$-10.0M$-4.0M$-1.0M$1.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-6.18
FCF Yield-9.45%
Quick Ratio2.29
Interest Coverage-9.30
Return 1Y
Return 3Y
Return 5Y

Ownership

Insiders Held11.89%
Institutions Held1.86%
Institutions Float Held2.11%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AYRWFAyr Wellness Inc. $0.00 -0.03 $467094 0.00%
AYURFAyurcann Holdings Corp. $0.00 $58411 0.00%
CBIHCannabis Bioscience International Holdings, Inc. $0.00 -0.01 $1.74M 0.00%
CLCFFChristina Lake Cannabis Corp. $0.02 +0.00% -2.27 $4.22M 0.00%
CRRTFCrescita Therapeutics, Inc. $0.56 +0.00% -43.17 $10.40M 0.00%

About Delivra Health Brands Inc.

Delivra Health Brands Inc., leveraging its operational subsidiaries, provides a varied selection of wellness and lifestyle products. These offerings are distributed to consumers and patients within regulated markets globally. The company's diverse product range includes cannabis-based items, liquid and powdered formulations for sleep, and topical creams designed for pain relief. Delivra Health Brands' primary corporate office is located in Vancouver, Canada.

Delivra Health Brands Inc. is headquartered in CA.

Delivra Health Brands Inc. (DHBUF) stock trades at $0.08 with a market capitalization of $2.59M. The stock is valued at a price-to-earnings (P/E) ratio of -3.40, price-to-book of 1.17, price-to-sales of 0.31. Over the past 52 weeks the stock has ranged between $0.05 and $0.26, and currently trades 69.2% below its 52-week high.

On profitability, Delivra Health Brands Inc. generates a return on equity (ROE) of -26.42%, return on capital employed of -19.32%, an operating margin of -8.52%, a net profit margin of -8.99%.

Official website: delivrahealthbrands.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides